CNBC's Silvia Amaro looks at how investors around the world are digesting news of President Donald Trump's 100% tariff on branded drugs, and whether Europe's pharma giants will avoid the worst impact.
Silvia Amaro is a correspondent at CNBC, based in London, where she specializes in European politics and financial markets. With a strong passion for these subjects, she has reported extensively on macroeconomics and issues surrounding economic inequality, earning recognition as the CFA UK Broadcast Journalist of the Year in 2021. Silvia's work has been featured in prominent outlets including Flipboard, NBC News, and CNBC.












